• 1. 2-Carbomethoxy-3-hydroxyquinoxaline-di-N-oxide as a novel ligand for the copper-catalyzed coupling reaction of phenols and aryl halides
  Yatao Qiu,Weijun Jia,Zhiyi Yao,Fanhong Wu,Sheng Jiang Org. Biomol. Chem. 2013 11 1502

• Solvents and Organic Chemicals Organic Compounds Aldehyde/Ketone

Professional Introduction to Compound with CAS No. 54916-28-8 and Product Name: 4'-(4-Methoxyphenoxy)acetophenone

The compound with the CAS number 54916-28-8 is a specialized chemical entity commonly referred to by the product name 4'-(4-Methoxyphenoxy)acetophenone. This compound has garnered significant attention in the field of pharmaceutical chemistry and bioorganic synthesis due to its unique structural and functional attributes. The presence of a methoxy group at the para position of the phenoxy ring and an acetophenone moiety at the other end imparts distinct reactivity and potential applications in medicinal chemistry.

Recent advancements in the study of 4'-(4-Methoxyphenoxy)acetophenone have highlighted its role as a versatile intermediate in the synthesis of biologically active molecules. The compound's structure allows for facile modifications, making it a valuable building block in drug discovery programs. Specifically, the methoxyphenoxy group can serve as a pharmacophore in designing molecules with enhanced solubility and metabolic stability, which are critical factors in pharmaceutical development.

In the realm of synthetic organic chemistry, 4'-(4-Methoxyphenoxy)acetophenone has been utilized in various cross-coupling reactions, including Suzuki-Miyaura and Stille couplings, which are pivotal for constructing complex molecular architectures. These reactions enable the introduction of diverse substituents, expanding the scope of derivatives that can be explored for pharmacological activity. The compound's compatibility with palladium-catalyzed transformations underscores its importance in modern synthetic methodologies.

One of the most compelling aspects of 4'-(4-Methoxyphenoxy)acetophenone is its potential application in the development of novel therapeutic agents. Research has demonstrated its utility as a precursor in the synthesis of kinase inhibitors, which are widely used to treat cancers and inflammatory diseases. The phenoxy group, in particular, has been shown to interact favorably with biological targets, enhancing binding affinity and selectivity. This has spurred interest among medicinal chemists seeking to develop next-generation small-molecule drugs.

The compound's pharmacokinetic profile has also been a subject of investigation. Studies indicate that derivatives of 4'-(4-Methoxyphenoxy)acetophenone exhibit favorable pharmacokinetic properties, including improved oral bioavailability and reduced toxicity. These attributes are essential for translating laboratory findings into clinical efficacy. Furthermore, computational modeling has been employed to predict how modifications to the structure of 4'-(4-Methoxyphenoxy)acetophenone can optimize its pharmacological activity, providing a rational framework for drug design.

From a synthetic perspective, 4'-(4-Methoxyphenoxy)acetophenone offers a balance between structural complexity and synthetic accessibility. The compound can be readily prepared through established synthetic routes, allowing researchers to focus on downstream functionalization rather than complex purification processes. This efficiency is particularly valuable in industrial settings where scalability and cost-effectiveness are paramount.

The role of 4'-(4-Methoxyphenoxy)acetophenone extends beyond academic research; it has found practical applications in contract research organizations (CROs) and pharmaceutical companies engaged in drug development. Its use as an intermediate has streamlined various synthetic pathways, reducing time-to-market for novel therapeutics. As the demand for personalized medicine grows, compounds like 4'-(4-Methoxyphenoxy)acetophenone will continue to play a crucial role in tailoring treatments to individual patient needs.

Future research directions may explore novel derivatives of 4'-(4-Methoxyphenoxy)acetophenone, particularly those with enhanced bioavailability or targeted delivery systems. Advances in nanotechnology have opened up possibilities for encapsulating these compounds within delivery vehicles, further improving their therapeutic potential. Additionally, green chemistry principles may be applied to develop more sustainable synthetic methods for producing 4'-(4-Methoxyphenoxy)acetophenone, aligning with global efforts to reduce environmental impact.

In summary, CAS No. 54916-28-8, identified as 4'-(4-Methoxyphenoxy)acetophenone, represents a significant advancement in pharmaceutical chemistry. Its unique structural features make it an invaluable intermediate for drug discovery and synthesis, with applications spanning from academic research to industrial-scale production. As our understanding of biological targets continues to evolve, compounds like this will remain at the forefront of medicinal chemistry innovation.

• 32852-92-9(1-(3-Phenoxyphenyl)ethanone)
• 54299-17-1(1,4-Bis(4-phenoxybenzoyl)benzene)
• 5031-78-7(1-(4-phenoxyphenyl)ethan-1-one)
• 106315-29-1(Methanone, [4-(4-phenoxyphenoxy)phenyl]phenyl-)
• 71815-31-1(Ethanone,1-[4-(4-methylphenoxy)phenyl]-)
• 14984-21-5(4,4'-Diphenoxybenzophenone)
• 887574-79-0(Ethanone,1-[4-(3-ethylphenoxy)phenyl]-)
• 6317-73-3(4-Phenoxybenzophenone)
• 2615-11-4(4,4'-Diacetyldiphenyl ether)
• 63347-89-7(Methanone, (oxydi-4,1-phenylene)bis[(4-phenoxyphenyl)-)